Last reviewed · How we verify

NCT05294874

Gait Rehabilitation in Diplegic Children

Completed NA Last updated 24 March 2022
What this trial tests

NA trial testing gait training in Cerebral Palsy in 45 participants. Completed in 25 November 2021.

Timeline
15 July 2021
Primary endpoint
14 November 2021
25 November 2021

Quick facts

Lead sponsorCairo University
PhaseNA
StatusCompleted
Study typeINTERVENTIONAL
Allocationrandomized
Designparallel
Maskingnone
Primary purposetreatment
Enrollment45
Start date15 July 2021
Primary completion14 November 2021
Estimated completion25 November 2021
Sites1 location across Egypt

Drugs / interventions tested

Conditions studied

Sponsor

Cairo University

Who can join

Adults 5 to 10, any sex, with Cerebral Palsy or Spastic Diplegia. Patients with the condition only — healthy volunteers not accepted.

Sponsor's own description

Background: Standing and walking serve an individual's basic need to move from place to place, and both are the most common activities that people do on a daily basis. Aim: to investigate the combined effect of botulinum toxin A (BoNT-A) injection and ankle weight on the gait of diplegic children who are using Ankle foot orthoses.

Publications & conference data

1 peer-reviewed publication reference this trial (live from Europe PMC):

  1. Gait Rehabilitation in Ambulant Diplegic Children Using Botulinum A Injection and Ankle Weights.
    Ibrahim NM, Galal Abdallah Ibrahim H, Alsayad T, Seddeek MI, et al · · 2022 · PMID 36683599 · DOI 10.1155/2022/6544813

Verify or expand the search:

Other trials of gait training

Trials testing the same drug.

Other recruiting trials for Cerebral Palsy

Currently open trials in the same condition.

Other Cairo University trials

Trials by the same sponsor.

Verify against primary sources

Data sources for this page

Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT05294874.

Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing